Arensia Eksploratori Medisin (შპს არენსია ექსპლორატორი მედისინ)

panel 2026-09-21Ask

as filed · GEL, thousands

financial ratiosXLSX

Ratio	2018	2019	2020	2021	2022	2023	2024
Margins
Gross Margin	100.0%	100.0%	53.3%	46.6%	44.5%	49.8%	49.8%
EBITDA Margin	10.9%	5.5%	6.8%	6.9%	8.8%	7.4%	8.5%
EBITDAR	541	431	610	752	832	793	1,012
EBITDAR Margin	19.7%	13.7%	12.9%	11.7%	12.6%	12.4%	13.2%
EBIT Margin	9.5%	4.5%	6.0%	6.3%	8.2%	6.5%	7.6%
Net Profit Margin	9.7%	4.8%	9.5%	4.6%	5.1%	5.5%	6.2%
Operating Expense % of Sales	89.1%	94.5%	46.6%	39.7%	35.7%	42.3%	41.4%
Returns
Return on Assets (ROA)	102.3%	74.2%	67.9%	33.0%	26.8%	21.9%	22.8%
Return on Equity (ROE)	112.3%	255.8%	91.4%	37.9%	30.2%	24.0%	24.3%
ROIC [EBIT / Invested Capital]	227.5%	N/A	87.5%	74.2%	80.2%	36.1%	33.1%
Leverage & debt balances
Debt-to-Assets	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Debt-to-Equity	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Debt-to-EBITDA	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Equity-to-Assets	91.1%	29.0%	74.3%	87.2%	88.8%	91.3%	93.9%
Net Debt	-122	-61	-164	-244	-452	-327	-184
Cash & Equivalents	122	61	164	244	452	327	184
Total Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Liquidity & working capital
Current Ratio	8.63x	0.72x	3.16x	6.72x	8.07x	10.28x	15.05x
Quick Ratio	8.63x	0.72x	3.16x	6.72x	8.07x	10.28x	15.05x
Cash Ratio	5.26x	0.43x	0.97x	2.11x	3.16x	2.32x	1.44x
Total Current Assets	200	103	532	777	1,151	1,448	1,925
Total Current Liabilities	23	143	169	116	143	141	128
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Trade Receivables	62	N/A	355	478	638	1,118	1,705
Trade Payables	23	143	145	116	143	141	128
Net Working Capital	177	-40	364	662	1,008	1,307	1,797
Net Working Capital % of Revenue	6.4%	-1.3%	7.7%	10.3%	15.2%	20.4%	23.4%
Trade Working Capital	39	-143	210	362	495	977	1,577
Trade Working Capital % of Revenue	1.4%	-4.5%	4.5%	5.7%	7.5%	15.3%	20.6%
Change in Trade Working Capital	N/A	-182	353	152	133	481	601
Turnover & efficiency
Inventory Turnover	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Days Inventory Outstanding (DIO)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Receivables Turnover	43.96x	N/A	13.26x	13.41x	10.39x	5.72x	4.50x
Days Sales Outstanding (DSO)	8.3	N/A	27.5	27.2	35.1	63.8	81.1
Payables Turnover	N/A	N/A	15.13x	29.56x	25.77x	22.81x	30.09x
Days Payable Outstanding (DPO)	N/A	N/A	24.1	12.3	14.2	16.0	12.1
Cash Conversion Cycle	8.3 days	N/A	3.4 days	14.9 days	21.0 days	47.8 days	69.0 days
Asset Turnover	10.56x	15.62x	7.17x	7.11x	5.23x	3.95x	3.68x
Cash flow & dividends
Operating Cash Flow	-33	25	130	80	207	N/A	N/A
Free Cash Flow (OCF − Capex proxy)	-51	-45	80	80	207	N/A	N/A
Cash Conversion (OCF / EBITDA)	-11.2%	14.5%	40.8%	18.0%	35.5%	N/A	N/A
Dividends Declared	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend Payout Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.

Arensia Eksploratori Medisin

Shareholders

Group structure

Directors & board

Key statistics

About

Revenue & margins

Financial statements

Ownership & group structure

Shareholders

Group structure

Directors & board

Peers